Characterization of "Yaa Chud" medicine on the Thailand-Myanmar border: Selecting for drug-resistant malaria and threatening public health
Multidrug-resistant Plasmodium falciparum malaria is a severe public health problem on the Thailand-Myanmar border. Many villagers buy packets of 4-5 mixed medicines ("yaa chud") from shops without medical assessment as their first-line malaria treatment. In 2000-2001 a local researcher pu...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
American Society of Tropical Medicine and Hygiene
2008
|
| Materias: | |
| Acceso en línea: | Registro en Scopus Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 14741caa a22016577a 4500 | ||
|---|---|---|---|
| 001 | PAPER-22506 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518205405.0 | ||
| 008 | 190411s2008 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-55849144034 | |
| 024 | 7 | |2 cas |a acetylsalicylic acid, 493-53-8, 50-78-2, 53663-74-4, 53664-49-6, 63781-77-1; alprenolol, 13655-52-2, 13707-88-5, 39405-98-6, 58615-82-0; amitriptyline, 50-48-6, 549-18-8; ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0; artemisinin, 63968-64-9; ascorbic acid, 134-03-2, 15421-15-5, 50-81-7; chloroquine, 132-73-0, 3545-67-3, 50-63-5, 54-05-7; chlorpheniramine, 132-22-9; diclofenac, 15307-79-6, 15307-86-5; dipyrone, 50567-35-6, 5907-38-0, 68-89-3; doxycycline, 10592-13-9, 17086-28-1, 564-25-0, 94088-85-4; indometacin, 53-86-1, 74252-25-8, 7681-54-1; nicotinamide, 11032-50-1, 98-92-0; paracetamol, 103-90-2; prazepam, 2955-38-6; prednisolone, 50-24-8; primaquine, 90-34-6; pyridoxine, 12001-77-3, 58-56-0, 65-23-6, 8059-24-3; quinine, 130-89-2, 130-95-0, 14358-44-2, 549-48-4, 549-49-5, 60-93-5, 7549-43-1; sulfamethoxazole, 723-46-6; tetracycline, 23843-90-5, 60-54-8, 64-75-5, 8021-86-1; thiamine, 59-43-8, 67-03-8; tolperisone, 3644-61-9, 728-88-1 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a AJTHA | ||
| 100 | 1 | |a Newton, P.N. | |
| 245 | 1 | 0 | |a Characterization of "Yaa Chud" medicine on the Thailand-Myanmar border: Selecting for drug-resistant malaria and threatening public health |
| 260 | |b American Society of Tropical Medicine and Hygiene |c 2008 | ||
| 270 | 1 | 0 | |m Newton, P. N.; Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; email: paul@tropmedres.ac |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K.L., Brockman, A., McGready, R., White, N.J., Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study (2000) Lancet, 356, pp. 297-302 | ||
| 504 | |a Price, R.N., Nosten, F., Drug resistant falciparum malaria: Clinical consequences and strategies for prevention (2001) Drug Resist Updat, 4, pp. 187-196 | ||
| 504 | |a Carrara, V.I., Sirilak, S., Thonglairuam, J., Rojanawatsirivet, C., Proux, S., Gilbos, V., Brockman, A., Nosten, F., Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: The Tak Malaria Initiative (2006) PLoS Med, 3, pp. e183 | ||
| 504 | |a White, N.J., Antimalarial drug resistance and combination chemotherapy (1999) Philos Trans R Soc Lond B Biol Sci, 354, pp. 739-749 | ||
| 504 | |a White, N.J., Antimalarial drug resistance (2004) J Clin Invest, 113, pp. 1084-1092 | ||
| 504 | |a Dondorp, A., Nosten, F., Stepniewska, K., Day, N., White, N., Artesunate versus quinine for treatment of severe falciparum malaria: A randomised trial (2005) Lancet, 366, pp. 717-725 | ||
| 504 | |a Jaidee, S., Limpananon, J., Wittayanartpaisal, S., Drug utilization of yaa-chud in Thailand (1980) Thai J Pharm Sci, 5, pp. 219-220 | ||
| 504 | |a Wiwat, C., Silapa-archa, W., Temsirilerkhul, R., Chiowatana, J., Rural self-medication in malaria infection (1982) Thai J Pharm Sci, 7, pp. 14-29 | ||
| 504 | |a Kamolratanakul, P., Dhanamun, B., Thaithong, S., Human behavior in relation to selection of malaria treatment (1992) Southeast Asian J Trop Med Public Health, 23, pp. 189-194 | ||
| 504 | |a Plasai, V., Spielman, A., Mefloquine insusceptibility of malaria in Thailand not promoted by nonregulated drug-use (1996) Acta Trop, 60, pp. 281-289 | ||
| 504 | |a Cunningham, C.E., Thai "injection doctors"; antibiotic mediators (1970) Soc Sci Med, 4, pp. 1-24 | ||
| 504 | |a Foster, S.D., Pricing, distribution, and use of antimalarial drugs (1991) Bull World Health Organ, 69, pp. 349-363 | ||
| 504 | |a Amin, A.A., Hughes, D.A., Marsh, V., Abuya, T.O., Kokwaro, G.O., Winstanley, P.A., Ochola, S.A., Snow, R.W., The difference between effectiveness and efficacy of antimalarial drugs in Kenya (2004) Trop Med Int Health, 9, pp. 967-974 | ||
| 504 | |a Basco, L.K., Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication (2004) Am J Trop Med Hyg, 70, pp. 245-250 | ||
| 504 | |a Goodman, C., Brieger, W., Unwin, A., Mills, A., Meek, S., Greer, G., Medicine sellers and malaria treatment in sub-Saharan Africa: What do they do and how can their practice be improved? (2007) Am J Trop Med Hyg, 77, pp. 203-218 | ||
| 504 | |a Brown, G.W., Saunders, J.P., Singh, S., Huxsoll, D.L., Shirai, A., Single dose doxycycline therapy for scrub typhus (1978) Trans R Soc Trop Med Hyg, 72, pp. 412-416 | ||
| 504 | |a Taylor, R.B., Shakoor, O., Behrens, R.H., Drug quality, a contributor to drug-resistance (1995) Lancet, 346, p. 122 | ||
| 504 | |a Okeke, I.N., Lamikanra, A., Edelman, R., Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries (1999) Emerg Infect Dis, 5, pp. 18-27 | ||
| 504 | |a Noranate, N., Durand, R., Tall, A., Marrama, L., Spiegel, A., Sokhna, C., Pradines, B., Mercereau-Puijalon, O., Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use (2007) PLoS ONE, 2, pp. e139 | ||
| 504 | |a Yeung, S., White, N.J., How do patients use antimalarial drugs? A review of the evidence (2005) Trop Med Int Health, 10, pp. 121-138 | ||
| 504 | |a Kachur, S.P., Black, C., Abdulla, S., Goodman, C., Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam (2006) Malar J, 5, p. 25 | ||
| 504 | |a Newton, P.N., Green, M.D., Fernandez, F.M., Day, N.P., White, N.J., Counterfeit anti-infective drugs (2006) Lancet Infect Dis, 6, pp. 602-613 | ||
| 504 | |a Fernandez, F.M., Cody, R.B., Green, M.D., Hampton, C.Y., McGready, R., Sengaloundeth, S., White, N.J., Newton, P.N., Characterization of solid counterfeit drug samples by desorption electrospray ionization and direct-analysis-in-real-time coupled to time-of-flight mass spectrometry (2006) ChemMedChem 1, pp. 702-705 | ||
| 504 | |a Hall, K.A., Newton, P.N., Green, M.D., De Veij, M., Vandenabeele, P., Pizzanelli, D., Mayxay, M., Fernandez, F.M., Characterization of counterfeit artesunate antimalarial tablets from southeast Asia (2006) Am J Trop Med Hyg, 75, pp. 804-811 | ||
| 504 | |a Ward, S.A., Sevene, E.J., Hastings, I.M., Nosten, F., McGready, R., Antimalarial drugs and pregnancy: Safety, pharmacokinetics, and pharmacovigilance (2007) Lancet Infect Dis, 7, pp. 136-144 | ||
| 504 | |a Lee, M.S., Kerns, E.H., LC/MS applications in drug development (1999) Mass Spectrom Rev, 18, pp. 187-279 | ||
| 504 | |a Tomer, K.B., Separations combined with mass spectrometry (2001) Chem Rev, 101, pp. 297-328 | ||
| 504 | |a Cody, R., Laramee, J., Durst, H., Versatile new ion source for the analysis of materials in open air under ambient conditions (2005) Anal Chem, 77, pp. 2297-2302 | ||
| 504 | |a Gaskell, S., Electrospray: Principles and practice (1997) J Mass Spectrom, 32, pp. 677-688 | ||
| 504 | |a (2008) WHO Model List of Essential Medicines, , Geneva: World Health Organization | ||
| 504 | |a (2006) WHO Guidelines for the Treatment of Malaria, , World Health Organization, Geneva: World Health Organization | ||
| 504 | |a Beers, M.H., Porter, R.S., Jones, T.V., Kaplan, J.L., Berwits, M., (2006) The Merck Manual of Diagnosis and Therapy, , Whitehouse Station, NJ: Merck Research Laboratories | ||
| 504 | |a (2007) British National Formulary, , London: BMJ Publishing Group and RPS Publishing. Anonymous | ||
| 504 | |a Ballereau, F., Prazuck, T., Schrive, I., Lafleuriel, M.T., Rozec, D., Fisch, A., Lafaix, C., Stability of essential drugs in the field: Results of a study conducted over a two-year period in Burkina Faso (1997) Am J Trop Med Hyg, 57, pp. 31-36 | ||
| 504 | |a Roper, C., Pearce, R., Nair, S., Sharp, B., Nosten, F., Anderson, T., Intercontinental spread of pyrimethamine-resistant malaria (2004) Science, 305, p. 1124 | ||
| 504 | |a Resistance to artemisinin derivatives along the Thai-Cambodian border (2007) Wkly Epidemiol Rec, 82, p. 360. , Anon | ||
| 504 | |a Bousema, J.T., Gouagna, L.C., Meutstege, A.M., Okech, B.E., Akim, N.I., Githure, J.I., Beier, J.C., Sauerwein, R.W., Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya (2003) Trop Med Int Health, 8, pp. 427-430 | ||
| 504 | |a Price, R., Nosten, F., Simpson, J.A., Luxemburger, C., Phaipun, L., ter Kuile, F., van Vugt, M., White, N.J., Risk factors for gametocyte carriage in uncomplicated falciparum malaria (1999) Am J Trop Med Hyg, 60, pp. 1019-1023 | ||
| 504 | |a Tomson, G., Sterky, G., Self-prescribing by way of pharmacies in 3 Asian developing-countries (1986) Lancet, 2, pp. 620-622 | ||
| 504 | |a Wondemagegnehu, E., Counterfeit and Substandard Drugs in Myanmar and Vietnam (1999) WHO Report, , Geneva: World Health Organization, WHO/EDM/QSM/993 | ||
| 504 | |a Lon, C.T., Tsuyuoka, R., Phanouvong, S., Nivanna, N., Socheat, D., Sokhan, C., Blum, N., Smine, A., Counterfeit and substandard antimalarial drugs in Cambodia (2006) Trans R Soc Trop Med Hyg, 100, pp. 1019-1024 | ||
| 504 | |a Patterson, A.E., Winch, P.J., Gilroy, K.E., Doumbia, S., Local terminology for medicines to treat fever in Bougouni District, Mali: Implications for the introduction and evaluation of malaria treatment policies (2006) Trop Med Int Health, 11, pp. 1613-1624 | ||
| 504 | |a Ratanowijitrasin, S., Wondemagegnehu, E., Effective drug regulation: A multicountry study (2003) Essent Drugs Monit, 32, pp. 2-4 | ||
| 520 | 3 | |a Multidrug-resistant Plasmodium falciparum malaria is a severe public health problem on the Thailand-Myanmar border. Many villagers buy packets of 4-5 mixed medicines ("yaa chud") from shops without medical assessment as their first-line malaria treatment. In 2000-2001 a local researcher purchased 50 yaa chud from 44 shops around Mae Sot, Thailand and Myawaddy, Myanmar (Burma), for his wife who was said to be pregnant with fever and drowsiness. The tablets/capsules were provisionally identified by appearance and active ingredients determined in a subset by using mass and atomic spectrometry. The most frequently detected active ingredients were acetaminophen (22%), chlorpheniramine (13.4%), chloroquine (12.6%), tetracycline/doxycycline (11.4%), and quinine (5.1%). Only seven bags contained potentially curative medicine for malaria. A total of 82% of the bags contained medicines contraindicated in pregnancy. Inappropriate, ineffective antimalarial drugs on the Thailand-Myanmar border are likely to increase malaria morbidity, mortality and health costs and engender the emergence and spread of antimalarial drug resistance. Copyright © 2008 by The American Society of Tropical Medicine and Hygiene. |l eng | |
| 593 | |a Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos | ||
| 593 | |a School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA 30332, United States | ||
| 593 | |a Wellcome Trust-Mahosot Hospital-Oxford Tropical Medicine Research Collaboration, Mahosot Hospital, Vientiane, Laos | ||
| 593 | |a Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, OX3 7LJ, United Kingdom | ||
| 593 | |a Faculty of Pharmacy, Mahidol University, Bangkok, Thailand | ||
| 593 | |a Mae Sot Hospital, Mae Sot, Tak Province, Thailand | ||
| 593 | |a Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 10400, Thailand | ||
| 593 | |a Departamento de Química Inorgánica, Analítica Y Química Física, Instituto de Quimica de Los Materiales, Medio Ambiente Y Energia, Ciudad Universitaria, 1428, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a ACETYLSALICYLIC ACID |
| 690 | 1 | 0 | |a ALPRENOLOL |
| 690 | 1 | 0 | |a AMITRIPTYLINE |
| 690 | 1 | 0 | |a AMPICILLIN |
| 690 | 1 | 0 | |a ANTACID AGENT |
| 690 | 1 | 0 | |a ARTEMISININ |
| 690 | 1 | 0 | |a ASCORBIC ACID |
| 690 | 1 | 0 | |a CHLOROQUINE |
| 690 | 1 | 0 | |a CHLORPHENIRAMINE |
| 690 | 1 | 0 | |a DICLOFENAC |
| 690 | 1 | 0 | |a DIPYRONE |
| 690 | 1 | 0 | |a DOXYCYCLINE |
| 690 | 1 | 0 | |a INDOMETACIN |
| 690 | 1 | 0 | |a NICOTINAMIDE |
| 690 | 1 | 0 | |a PARACETAMOL |
| 690 | 1 | 0 | |a PRAZEPAM |
| 690 | 1 | 0 | |a PREDNISOLONE |
| 690 | 1 | 0 | |a PRIMAQUINE |
| 690 | 1 | 0 | |a PYRIDOXINE |
| 690 | 1 | 0 | |a QUININE |
| 690 | 1 | 0 | |a SULFAMETHOXAZOLE |
| 690 | 1 | 0 | |a TETRACYCLINE |
| 690 | 1 | 0 | |a THIAMINE |
| 690 | 1 | 0 | |a TOLPERISONE |
| 690 | 1 | 0 | |a ACIDOSIS |
| 690 | 1 | 0 | |a AGRANULOCYTOSIS |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a ATOMIC ABSORPTION SPECTROMETRY |
| 690 | 1 | 0 | |a BRADYCARDIA |
| 690 | 1 | 0 | |a DISEASE SEVERITY |
| 690 | 1 | 0 | |a DROWSINESS |
| 690 | 1 | 0 | |a DRUG CAPSULE |
| 690 | 1 | 0 | |a DRUG EFFICACY |
| 690 | 1 | 0 | |a GASTROINTESTINAL IRRITATION |
| 690 | 1 | 0 | |a HEALTH CARE COST |
| 690 | 1 | 0 | |a HEMOLYSIS |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HYPOGLYCEMIA |
| 690 | 1 | 0 | |a MASS SPECTROMETRY |
| 690 | 1 | 0 | |a METHEMOGLOBINEMIA |
| 690 | 1 | 0 | |a MORBIDITY |
| 690 | 1 | 0 | |a MORTALITY |
| 690 | 1 | 0 | |a MULTIDRUG RESISTANCE |
| 690 | 1 | 0 | |a MYANMAR |
| 690 | 1 | 0 | |a NEWBORN HEMOLYTIC DISEASE |
| 690 | 1 | 0 | |a PLASMODIUM FALCIPARUM |
| 690 | 1 | 0 | |a RASH |
| 690 | 1 | 0 | |a STOMACH IRRITATION |
| 690 | 1 | 0 | |a TABLET |
| 690 | 1 | 0 | |a THAILAND |
| 690 | 1 | 0 | |a TINNITUS |
| 690 | 1 | 0 | |a PLASMODIUM FALCIPARUM |
| 650 | 1 | 7 | |2 spines |a MALARIA |
| 653 | 0 | 0 | |a tylenol, McNeil, United States |
| 700 | 1 | |a Hampton, C.Y. | |
| 700 | 1 | |a Alter-Hall, K. | |
| 700 | 1 | |a Teerwarakulpana, T. | |
| 700 | 1 | |a Prakongpan, S. | |
| 700 | 1 | |a Ruangveerayuth, R. | |
| 700 | 1 | |a White, N.J. | |
| 700 | 1 | |a Day, N.P.J. | |
| 700 | 1 | |a Tudino, M.B. | |
| 700 | 1 | |a Mancuso, N. | |
| 700 | 1 | |a Fernández, F.M. | |
| 773 | 0 | |d American Society of Tropical Medicine and Hygiene, 2008 |g v. 79 |h pp. 662-669 |k n. 5 |p Am. J. Trop. Med. Hyg. |x 00029637 |t American Journal of Tropical Medicine and Hygiene | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-55849144034&partnerID=40&md5=ead357e03048b7a39d4d96be9cfa4b79 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_00029637_v79_n5_p662_Newton |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00029637_v79_n5_p662_Newton |y Registro en la Biblioteca Digital |
| 961 | |a paper_00029637_v79_n5_p662_Newton |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 83459 | ||